Wednesday, November 05, 2025 BRC5 (Alliance B140503) secondary analysis publication: Additional node dissection in the BRC5 trial was performed at the surgeon's discretion and included simple sampling, systematic sampling, or complete lymph node dissection. Researchers report the impact of the extent of lymphadenectomy on disease- and recurrence-free survival in this trial. Altorki N, Damman B, Wang X, Liberman M, Wigle D, Ashrafi A, Conti M, Yasufuku K, Schuchert MJ, Stinchcombe TE. The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B140503 (Alliance). The Journal of Thoracic and Cardiovascular Surgery 170: 933-942.e2. 2025. https://doi.org/10.1016/j.jtcvs.2025.06.007
